InsiderTrades

Form 4 for APVO Aptevo Therapeutics Inc.

Accepted 2023-08-10 00:00:00 ET · period of report 2023-08-08 · accession 0001209191-23-045263 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-08-10 2023-08-08 APVO Lamothe Jeffrey G. EVP, COO M - OptEx — +13.8K 26.5K +109% —
DM 2023-08-10 2023-08-08 APVO Lamothe Jeffrey G. EVP, COO M - OptEx $0.00 -13.8K 3,667 -79% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-08 M A 11,979 — 24,671 D — — (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
2 Common Common Stock 2023-08-08 M A 1,833 — 26,504 D — — (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
3 Derivative Restricted Stock Unit 2023-08-08 M D 11,979 $0.00 11,979 D — · — to — 11,979 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On August 9, 2022, the reporting person was granted 23,958 RSUs, vesting in two approximately equal installments beginning on August 8, 2023.
4 Derivative Restricted Stock Unit 2023-08-08 M D 1,833 $0.00 3,667 D — · — to — 1,833 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F3) On August 9, 2022, the reporting person was granted 5,500 RSUs, vesting in three approximately equal installments beginning on August 8, 2023.